Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin
Open Access
- 15 May 2014
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 306 (10) , G839-G848
Abstract
Substance P (SP) is commonly coexpressed with ACh in enteric motor neurons, and, according to the classical paradigm, both these neurotransmitters excite smooth muscle via parallel pathways. We hypothesized that, in addition, SP was responsible for maintaining the muscular responsiveness to ACh. We tested this hypothesis by using botulinum toxin (BoNT/A), a known blocker of vesicular release of neurotransmitters including ACh and neuropeptides. BoNT/A was injected into rat pyloric sphincter in different doses; as control we used boiled BoNT/A. At the desired time point, pylorus was dissected out and pyloric contractility was measured ex vivo in an organ bath and by measuring phosphorylation of myosin light chain 20 (MLC20). BoNT/A (10 IU) significantly reduced the response of pyloric muscle to exogenous ACh, an effect that was accompanied by reduced MLC20 phosphorylation in the muscle. Both effects were reversed by exogenous SP. CP-96345, a NK1 receptor antagonist, blocked the ability of exogenous SP to reverse the cholinergic hyporesponsiveness as well as the reduction in MLC20 phosphorylation induced by BoNT/A. In conclusion, we have identified a novel role for SP as a coneurotransmitter that appears to be important for the maintenance of muscular responsiveness to the principal excitatory neurotransmitter, ACh. These results also provide new insight into the effects of botulinum toxin on the enteric nervous system and gastrointestinal smooth muscle.Keywords
This publication has 35 references indexed in Scilit:
- Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivoCanadian Journal of Physiology and Pharmacology, 2007
- The Therapeutic Potential of Botulinum ToxinDermatologic Surgery, 2004
- Botulinum toxin for spastic GI disorders: a systematic reviewGastrointestinal Endoscopy, 2003
- Botulinum toxin for spastic gastrointestinal disordersBest Practice & Research Clinical Gastroenterology, 1999
- Tachykinin receptors and intestinal motilityCanadian Journal of Physiology and Pharmacology, 1997
- Tachykinin receptors and intestinal motilityCanadian Journal of Physiology and Pharmacology, 1997
- Coexpression of vasoactive intestinal peptide, calcitonin gene-related peptide and substance P immunoreactivity in parasympathetic neurons of the rhesus monkey lungNeuroscience Letters, 1995
- Inhibitory effect of CP-96,345, a non-peptide neurokinin-1-receptor antagonist, on neurogenic responses of guinea-pig isolated airway smooth muscleJournal of Pharmacy and Pharmacology, 1993
- Role of pylorus in mediating cholecystokinin-stimulated satiety in the Zucker ratDigestive Diseases and Sciences, 1986
- On the nature of the contractile motor responses of the rat stomach elicited by serotonin or substance Pin vitroJournal of Neural Transmission, 1985